73 related articles for article (PubMed ID: 33611761)
1. MMSE is an independent prognostic factor for survival in primary central nervous system lymphoma.
van der Meulen M; Dirven L; Bakunina K; van den Bent MJ; Issa S; Doorduijn JK; Bromberg JEC
J Neurooncol; 2021 Apr; 152(2):357-362. PubMed ID: 33611761
[TBL] [Abstract][Full Text] [Related]
2. Survival, neurocognitive function, and health-related quality of life outcomes after rituximab-methotrexate, BCNU, teniposide, and prednisolone for primary CNS lymphoma: Final results of the HOVON 105/ALLG NHL 24 study.
Bromberg JEC; Issa S; van der Holt B; van der Meulen M; Dirven L; Minnema MC; Seute T; Durian M; Cull G; van der Poel MWM; Stevens WBC; Zijlstra JM; Brandsma D; Nijland M; Mason KD; Beeker A; Abrahamse-Testroote MCJ; van den Bent MJ; de Jong D; Doorduijn JK
Neuro Oncol; 2024 Apr; 26(4):724-734. PubMed ID: 38037691
[TBL] [Abstract][Full Text] [Related]
3. Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 U.S. cancer centers.
David KA; Sundaram S; Kim SH; Vaca R; Lin Y; Singer S; Malecek MK; Carter J; Zayac A; Kim MS; Reddy N; Ney D; Habib A; Strouse C; Graber J; Bachanova V; Salman S; Vendiola JA; Hossain N; Tsang M; Major A; Bond DA; Agrawal P; Mier-Hicks A; Torka P; Rajakumar P; Venugopal P; Berg S; Glantz M; Goldlust SA; Folstad M; Kumar P; Ollila TA; Cai J; Spurgeon S; Sieg A; Cleveland J; Chang J; Epperla N; Karmali R; Naik S; Martin P; Smith SM; Rubenstein J; Kahl B; Evens AM
Am J Hematol; 2023 Jun; 98(6):900-912. PubMed ID: 36965007
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of POD18 combined with improved IELSG in primary central nervous system lymphoma.
Du KX; Shen HR; Pan BH; Luthuli S; Wang L; Liang JH; Li Y; Yin H; Li JY; Wu JZ; Xu W
Clin Transl Oncol; 2024 Mar; 26(3):720-731. PubMed ID: 37558851
[TBL] [Abstract][Full Text] [Related]
5. Different patterns of failure in two treatment regimens for primary central nervous system lymphoma, a retrospective analysis of 124 cases in Taiwan.
Chuang CH; Kuo MC; Chang H; Wu JH; Hung YS; Ou CW; Lin TL; Su YJ; Ong YC; Shih LY; Kao HW
Clin Exp Med; 2023 Dec; 23(8):5327-5336. PubMed ID: 37679606
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Memorial Sloan-Kettering Cancer Center and International Extranodal Lymphoma Study Group prognostic scoring systems to predict Overall Survival in intracranial Primary CNS lymphoma.
Jahr G; Broi MD; Holte H; Beiske K; Meling TR
Brain Behav; 2018 Mar; 8(3):e00928. PubMed ID: 29541540
[TBL] [Abstract][Full Text] [Related]
7. Relevance of different prognostic scores in primary CNS lymphoma in the era of intensified treatment regimens: A retrospective, multicenter analysis of 174 patients.
Zeremski V; Adolph L; Beer S; Berisha M; Jacobs B; Kahl C; Koenecke C; Kropf S; Panse J; Petersen J; Schmidt-Hieber M; Schneider J; Vucinic V; Walter J; Weigert O; Witte HM; Mougiakakos D
Eur J Haematol; 2024 Apr; 112(4):641-649. PubMed ID: 38164819
[TBL] [Abstract][Full Text] [Related]
8. Role of Rituximab in Treatment of Patients With Primary Central Nervous System Lymphoma (PCNSL): A Systematic Review and Meta-Analysis.
Zhang Y; Liu Z; Gao C; Bian H; Ma Y; Jing F; Zhao X
Clin Lymphoma Myeloma Leuk; 2023 Oct; 23(10):733-741. PubMed ID: 37453867
[TBL] [Abstract][Full Text] [Related]
9. C-reactive protein levels, the prognostic nutritional index, and the lactate dehydrogenase-to-lymphocyte ratio are important prognostic factors in primary central nervous system lymphoma: a single-center study of 223 patients.
Zuo J; Lei T; Zhong S; Zhou J; Liu R; Wu C; Li S
Neurosurg Rev; 2023 Dec; 47(1):17. PubMed ID: 38112846
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of progression-free survival as a surrogate end point in primary CNS lymphoma: a systematic review and meta-analysis.
Zhan J; Yang S; Zhang W; Zhou D; Zhao D; Zhang Y; Wang W; Wei C
Future Oncol; 2023 Oct; 19(31):2123-2133. PubMed ID: 37882339
[No Abstract] [Full Text] [Related]
11. The role of comorbidity indices and histochemical markers in surgically resected and non-resected primary central nervous system lymphoma.
Wong CE; Liao WA; Chang Y; Lee PH; Huang CC; Chang KC; Lee JS
Clin Exp Med; 2023 Nov; 23(7):3799-3807. PubMed ID: 37491648
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of meningeal dissemination in primary CNS lymphoma (PCNSL): experience from the G-PCNSL-SG1 trial.
Korfel A; Weller M; Martus P; Roth P; Klasen HA; Roeth A; Rauch M; Hertenstein B; Fischer T; Hundsberger T; Leithäuser M; Birnbaum T; Kirchen H; Mergenthaler HG; Schubert J; Berdel W; Birkmann J; Hummel M; Thiel E; Fischer L
Ann Oncol; 2012 Sep; 23(9):2374-2380. PubMed ID: 22396446
[TBL] [Abstract][Full Text] [Related]
13. Survival outcomes and treatment experience of 124 patients with primary central nervous system lymphoma.
Tang Z; Wu G; Tan F; Long Y; Hong J; Lyu Z; Wei R
Strahlenther Onkol; 2024 Mar; ():. PubMed ID: 38466403
[TBL] [Abstract][Full Text] [Related]
14. Surgical resection versus biopsy in the treatment of primary central nervous system lymphoma: a systematic review and meta-analysis.
Chojak R; Koźba-Gosztyła M; Polańska K; Rojek M; Chojko A; Bogacz R; Skorupa N; Więcław J; Czapiga B
J Neurooncol; 2022 Dec; 160(3):753-761. PubMed ID: 36449256
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the genomic landscape of primary central nervous system lymphoma using whole-genome sequencing in Chinese patients.
Yuan X; Yu T; Zhao J; Jiang H; Hao Y; Lei W; Liang Y; Li B; Qian W
Front Med; 2023 Oct; 17(5):889-906. PubMed ID: 37418076
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of interleukin-10 concentration in the cerebrospinal fluid of patients with primary central nervous system lymphoma.
Geng M; Song Y; Xiao H; Wu Z; Deng X; Chen C; Wang G
Oncol Lett; 2021 Jan; 21(1):2. PubMed ID: 33240408
[TBL] [Abstract][Full Text] [Related]
17. Machine learning-based pathomics signature of histology slides as a novel prognostic indicator in primary central nervous system lymphoma.
Duan L; He Y; Guo W; Du Y; Yin S; Yang S; Dong G; Li W; Chen F
J Neurooncol; 2024 Apr; ():. PubMed ID: 38557926
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of Beta 2-Microglobulinin in cerebrospinal fluid in primary central nervous system lymphoma.
Bertucci A; Boucard C; Harlay V; Appay R; Petrirena G; Barrié M; Chinot O; Tabouret E
J Neurol Sci; 2024 Feb; 457():122847. PubMed ID: 38129260
[No Abstract] [Full Text] [Related]
19. Prognostic impact of neurocognitive disorders in older patients with cancer: the ELCAPA prospective cohort study.
Conti C; Paillaud E; Laurent M; Poisson J; Boudou-Rouquette P; Frelaut M; Gay P; Canovas J; Caillet P; Mebarki S; Broussier A; Canouï-Poitrine F
J Nutr Health Aging; 2024 Mar; 28(5):100215. PubMed ID: 38518539
[TBL] [Abstract][Full Text] [Related]
20. The prognostic impact of lymphoma perforation in patients with primary gastrointestinal lymphoma - a single-center analysis.
Modemann F; Ahmadi P; von Kroge PH; Weidemann S; Bokemeyer C; Dierlamm J; Fiedler W; Ghandili S
Leuk Lymphoma; 2023; 64(11):1801-1810. PubMed ID: 37552203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
